insights_auto
Why is GE9 up 2.43%?
Dive Deeperchevron_right
GE9:ETR
Genmab A/S
€341.30
arrow_upward
+2.43%(+8.10) 1D
Oct 19, 5:35:53 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GE9...
Open
€335.60
High
€341.30
Low
€332.80
Mkt. cap
24.39B
Avg. vol.
119.00
Volume
275.00
52-wk high
€346.30
52-wk low
€203.50
No. of employees
3K
Open
€335.60
High
€341.30
Low
€332.80
Mkt. cap
24.39B
Avg. vol.
119.00
Volume
275.00
52-wk high
€346.30
52-wk low
€203.50
No. of employees
3K
News stories
From web sources and news partners
TradingView
·
22 minutes ago
There is no fundamental reason for stocks’ reversal, says SA analyst
Devdiscourse
·
32 minutes ago
US STOCKS-Nasdaq climbs as chip and AI-linked stocks bounce back
The Motley Fool
·
57 minutes ago
3 Unstoppable Dow Stocks to Buy Before October Ends
Investing.com
·
18 minutes ago
Dow Jones stalls at key resistance 52,430: Live levels
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12K
Founded1999
Headquarters-
SectorBiotechnology
Websitegenmab.com